Published in Euro Surveill on April 11, 2013
Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ (2013) 4.17
Characterization of H7N9 influenza A viruses isolated from humans. Nature (2013) 3.71
The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature (2013) 3.60
Receptor binding by an H7N9 influenza virus from humans. Nature (2013) 2.33
Identification, characterization, and natural selection of mutations driving airborne transmission of A/H5N1 virus. Cell (2014) 2.23
Pathogenicity of the novel A/H7N9 influenza virus in mice. MBio (2013) 1.49
Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts. J Virol (2014) 1.39
Mapping spread and risk of avian influenza A (H7N9) in China. Sci Rep (2013) 1.38
Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design. Hum Vaccin Immunother (2013) 1.38
Preferential recognition of avian-like receptors in human influenza A H7N9 viruses. Science (2013) 1.37
Adaptation of novel H7N9 influenza A virus to human receptors. Sci Rep (2013) 1.31
Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin. J Virol (2013) 1.26
Antigenic and molecular characterization of avian influenza A(H9N2) viruses, Bangladesh. Emerg Infect Dis (2013) 1.19
H7N9 influenza viruses interact preferentially with α2,3-linked sialic acids and bind weakly to α2,6-linked sialic acids. J Gen Virol (2013) 1.19
Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. Viruses (2014) 1.18
Pandemic potential of avian influenza A (H7N9) viruses. Trends Microbiol (2014) 1.16
Influenza viruses: breaking all the rules. MBio (2013) 1.14
Novel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig model. J Virol (2013) 1.09
Rapid and sensitive detection of novel avian-origin influenza A (H7N9) virus by reverse transcription loop-mediated isothermal amplification combined with a lateral-flow device. PLoS One (2013) 1.09
Virulence-affecting amino acid changes in the PA protein of H7N9 influenza A viruses. J Virol (2013) 1.06
Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets. J Virol (2014) 1.04
The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome. J Infect Dis (2013) 1.03
Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection. Emerg Microbes Infect (2013) 1.00
H7N9 influenza-the laboratory presentations: a letter to editor. Asian Pac J Trop Biomed (2013) 1.00
Development and evaluation of a SYBR green-based real time RT-PCR assay for detection of the emerging avian influenza A (H7N9) virus. PLoS One (2013) 1.00
The effect of the PB2 mutation 627K on highly pathogenic H5N1 avian influenza virus is dependent on the virus lineage. J Virol (2013) 0.99
H7N9 Influenza: The Emerging Infectious Disease. N Am J Med Sci (2013) 0.99
Transmission of influenza A viruses. Virology (2015) 0.99
Risk assessment on the epidemics of human infection with a novel avian influenza A (H7N9) virus in Jiangsu Province, China. J Biomed Res (2013) 0.98
Serological and virological surveillance of avian influenza A virus H9N2 subtype in humans and poultry in Shanghai, China, between 2008 and 2010. Zoonoses Public Health (2014) 0.97
Towards a better understanding of the novel avian-origin H7N9 influenza A virus in China. Sci Rep (2013) 0.96
Epidemiology of the avian influenza A (H7N9) outbreak in Zhejiang Province, China. BMC Infect Dis (2014) 0.96
Host restriction of influenza virus polymerase activity by PB2 627E is diminished on short viral templates in a nucleoprotein-independent manner. J Virol (2013) 0.95
Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design. Hum Vaccin Immunother (2014) 0.95
Seasonal Influenza Can Poise Hosts for CD4 T-Cell Immunity to H7N9 Avian Influenza. J Infect Dis (2014) 0.93
Analysis of recombinant H7N9 wild-type and mutant viruses in pigs shows that the Q226L mutation in HA is important for transmission. J Virol (2014) 0.93
Identification of amino acid changes that may have been critical for the genesis of A(H7N9) influenza viruses. J Virol (2014) 0.93
Alternative reassortment events leading to transmissible H9N1 influenza viruses in the ferret model. J Virol (2013) 0.91
A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulence. J Virol (2014) 0.90
Historical prevalence and distribution of avian influenza virus A(H7N9) among wild birds. Emerg Infect Dis (2013) 0.90
Mutations to PB2 and NP proteins of an avian influenza virus combine to confer efficient growth in primary human respiratory cells. J Virol (2014) 0.90
Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts. Sci Rep (2015) 0.90
Avian influenza H7N9/13 and H7N7/13: a comparative virulence study in chickens, pigeons, and ferrets. J Virol (2014) 0.89
Sampling strategies and biodiversity of influenza A subtypes in wild birds. PLoS One (2014) 0.89
The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA. J Virol (2014) 0.89
Cellular changes in blood indicate severe respiratory disease during influenza infections in mice. PLoS One (2014) 0.88
H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance. Hum Vaccin Immunother (2015) 0.88
Development of reverse-transcription loop-mediated isothermal amplification assay for rapid detection of novel avian influenza A (H7N9) virus. BMC Microbiol (2014) 0.88
Possible role of songbirds and parakeets in transmission of influenza A(H7N9) virus to humans. Emerg Infect Dis (2014) 0.87
A new piece in the puzzle of the novel avian-origin influenza A (H7N9) virus. Biol Direct (2013) 0.87
Comparison of characteristics between patients with H7N9 living in rural and urban areas of Zhejiang Province, China: a preliminary report. PLoS One (2014) 0.86
Characterization of influenza A (H7N9) viruses isolated from human cases imported into Taiwan. PLoS One (2015) 0.86
Influenza A(H7N9) virus transmission between finches and poultry. Emerg Infect Dis (2015) 0.86
Glycan receptor specificity as a useful tool for characterization and surveillance of influenza A virus. Trends Microbiol (2014) 0.86
Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity. Sci Rep (2013) 0.86
Molecular mechanism of the airborne transmissibility of H9N2 avian influenza A viruses in chickens. J Virol (2014) 0.85
Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor. PLoS One (2014) 0.82
Novel avian-origin influenza A (H7N9) virus attachment to the respiratory tract of five animal models. J Virol (2014) 0.82
Human H7N9 avian influenza virus infection: a review and pandemic risk assessment. Emerg Microbes Infect (2013) 0.82
Human H7N9 influenza A viruses replicate in swine respiratory tissue explants. J Virol (2013) 0.82
Estimating Human Cases of Avian Influenza A(H7N9) from Poultry Exposure. PLoS Curr (2013) 0.82
Fluorescent immunochromatography for rapid and sensitive typing of seasonal influenza viruses. PLoS One (2015) 0.82
First outbreaks and phylogenetic analyses of avian influenza H9N2 viruses isolated from poultry flocks in Morocco. Virol J (2016) 0.81
Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses. Hum Vaccin Immunother (2014) 0.81
Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic. Clin Infect Dis (2015) 0.81
Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review. Ecohealth (2015) 0.80
Genome Sequence of a Novel H10N9 Avian Influenza Virus Isolated from Chickens in a Live Poultry Market in Eastern China. Genome Announc (2013) 0.80
3D Molecular Modelling Study of the H7N9 RNA-Dependent RNA Polymerase as an Emerging Pharmacological Target. Influenza Res Treat (2013) 0.80
An overview of the characteristics of the novel avian influenza A H7N9 virus in humans. Front Microbiol (2015) 0.80
Respiratory Mucosal Proteome Quantification in Human Influenza Infections. PLoS One (2016) 0.79
Virulence determinants in the PB2 gene of a mouse-adapted H9N2 virus. J Virol (2014) 0.79
Phylogenetic Analysis and Pathogenicity Assessment of Two Strains of Avian Influenza Virus Subtype H9N2 Isolated from Migratory Birds: High Homology of Internal Genes with Human H10N8 Virus. Front Microbiol (2016) 0.79
Survival analysis of infected mice reveals pathogenic variations in the genome of avian H1N1 viruses. Sci Rep (2014) 0.79
Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates. Antimicrob Agents Chemother (2015) 0.79
FluKB: A Knowledge-Based System for Influenza Vaccine Target Discovery and Analysis of the Immunological Properties of Influenza Viruses. J Immunol Res (2015) 0.79
Quantifying the fitness advantage of polymerase substitutions in Influenza A/H7N9 viruses during adaptation to humans. PLoS One (2013) 0.79
Evolution of influenza A virus H7 and N9 subtypes, Eastern Asia. Emerg Infect Dis (2013) 0.79
Detecting Spread of Avian Influenza A(H7N9) Virus Beyond China. Emerg Infect Dis (2015) 0.79
Influenza virus A/Anhui/1/2013 (H7N9) replicates efficiently in the upper and lower respiratory tracts of cynomolgus macaques. MBio (2014) 0.79
Preliminary success in the characterization and management of a sudden breakout of a novel H7N9 influenza A virus. Int J Biol Sci (2014) 0.79
CHD3 facilitates vRNP nuclear export by interacting with NES1 of influenza A virus NS2. Cell Mol Life Sci (2014) 0.78
Transmission of H7N9 Influenza Viruses with a Polymorphism at PB2 Residue 627 in Chickens and Ferrets. J Virol (2015) 0.78
Simultaneous detection of novel H7N9 and other influenza A viruses in poultry by multiplex real-time RT-PCR. Virol J (2015) 0.78
Identification of Influenza A/H7N9 virus infection-related human genes based on shortest paths in a virus-human protein interaction network. Biomed Res Int (2014) 0.78
Joint China-US Call for Employing a Transdisciplinary Approach to Emerging Infectious Diseases. Ecohealth (2015) 0.77
Preexisting CD4+ T-cell immunity in human population to avian influenza H7N9 virus: whole proteome-wide immunoinformatics analyses. PLoS One (2014) 0.77
Characterization of H7 influenza A virus in wild and domestic birds in Korea. PLoS One (2014) 0.77
Using quantitative disease dynamics as a tool for guiding response to avian influenza in poultry in the United States of America. Prev Vet Med (2013) 0.77
Deadly H7N9 influenza virus: a pandemic in the making or a warning lesson? Am J Respir Crit Care Med (2013) 0.77
Full Genome Sequence of a Natural Reassortant H9N2 Avian Influenza Virus Isolated from Domestic Ducks in Jiangsu Province, China. Genome Announc (2013) 0.76
Novel avian influenza A (H7N9) virus induces impaired interferon responses in human dendritic cells. PLoS One (2014) 0.76
Replication Capacity of Avian Influenza A(H9N2) Virus in Pet Birds and Mammals, Bangladesh. Emerg Infect Dis (2015) 0.76
Evolution and ecology of influenza A viruses. Microbiol Rev (1992) 39.99
Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science (2001) 24.48
Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61
Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell (2000) 20.83
Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science (2001) 18.43
Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90
A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A (2000) 12.16
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol (1998) 8.44
Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol (2000) 8.28
Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology (1994) 8.06
Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology (1998) 7.99
The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J Virol (1999) 7.89
Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science (1995) 7.77
The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med (2001) 7.49
Phenanthrenequinone as an analytical reagent for arginine and other monosubstituted guanidines. Biochim Biophys Acta (1966) 7.11
A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A (1997) 6.86
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics (1996) 6.83
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature (1986) 6.67
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell (1999) 6.40
Green revolution: a mutant gibberellin-synthesis gene in rice. Nature (2002) 5.84
Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med (1999) 5.55
Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science (1999) 5.53
Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature (1996) 5.32
Fetal growth and perinatal viability in California. Obstet Gynecol (1982) 5.23
Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol (1999) 5.21
Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest (2000) 5.07
TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell (2001) 4.60
A prokaryotic voltage-gated sodium channel. Science (2001) 4.56
Genetic reassortment between avian and human influenza A viruses in Italian pigs. Virology (1993) 4.40
Potential for transmission of avian influenza viruses to pigs. J Gen Virol (1994) 4.24
Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology (1984) 4.15
Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis (1996) 4.04
Evolution of influenza A virus nucleoprotein genes: implications for the origins of H1N1 human and classical swine viruses. J Virol (1991) 4.01
Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother (2003) 3.90
Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve (1995) 3.84
Intraneuronal Abeta42 accumulation in human brain. Am J Pathol (2000) 3.83
TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem (1997) 3.81
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Function of GATA transcription factors in preadipocyte-adipocyte transition. Science (2000) 3.60
Failure to synthesize the T cell CD3-zeta chain: structure and function of a partial T cell receptor complex. Cell (1988) 3.59
Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. Virology (1993) 3.54
Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol (2000) 3.54
Biologic importance of neuraminidase stalk length in influenza A virus. J Virol (1993) 3.51
Ebola virus VP40-induced particle formation and association with the lipid bilayer. J Virol (2001) 3.41
Evolution of influenza A virus PB2 genes: implications for evolution of the ribonucleoprotein complex and origin of human influenza A virus. J Virol (1990) 3.40
Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet (1998) 3.38
Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts. J Virol (1992) 3.37
Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev (2001) 3.33
Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med (1992) 3.31
Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J Virol (1994) 3.31
Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. J Virol (1991) 3.29
The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J Virol (1998) 3.25
Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. Clin Pharmacol Ther (2012) 3.16
Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology (1997) 3.10
Sialic acid species as a determinant of the host range of influenza A viruses. J Virol (2000) 3.10
Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J Virol (1998) 3.07
Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J Virol (1997) 3.00
Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico. Virology (1995) 2.99
Promoter elements in the influenza vRNA terminal structure. RNA (1996) 2.97
The emerging role of electronic medical records in pharmacogenomics. Clin Pharmacol Ther (2011) 2.93
Human RNase III is a 160-kDa protein involved in preribosomal RNA processing. J Biol Chem (2000) 2.88
A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc Natl Acad Sci U S A (1998) 2.86
Automated analysis of protein NMR assignments using methods from artificial intelligence. J Mol Biol (1997) 2.86
Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81
Function of the 30 kd protein of tobacco mosaic virus: involvement in cell-to-cell movement and dispensability for replication. EMBO J (1987) 2.78
Experimental investigation of geologically produced antineutrinos with KamLAND. Nature (2005) 2.75
Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature. J Virol (1985) 2.75
Cloning and complete nucleotide sequence of the Escherichia coli glutamine permease operon (glnHPQ). Mol Gen Genet (1986) 2.73
Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity (1995) 2.70
Nuclear import and export of influenza virus nucleoprotein. J Virol (1997) 2.69
Requirement of CD9 on the egg plasma membrane for fertilization. Science (2000) 2.65
Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J Exp Med (1996) 2.62
Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity (1994) 2.61
Functionally related motor neuron pool and muscle sensory afferent subtypes defined by coordinate ETS gene expression. Cell (1998) 2.57
Temperature-induced A-B intersite charge transfer in an A-site-ordered LaCu(3)Fe(4)O(12) perovskite. Nature (2009) 2.57
Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Arterioscler Thromb Vasc Biol (1999) 2.56
Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J (2000) 2.54
Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol (2001) 2.52
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer (2010) 2.51
An extracellular poly(3-hydroxybutyrate) depolymerase from Alcaligenes faecalis. Eur J Biochem (1982) 2.49
Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 alpha subunit. Circ Res (1998) 2.48
Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci U S A (2001) 2.46
Emergence of avian H1N1 influenza viruses in pigs in China. J Virol (1996) 2.44
Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol (1999) 2.41
CDC14 of Saccharomyces cerevisiae. Cloning, sequence analysis, and transcription during the cell cycle. J Biol Chem (1992) 2.41
Evolution of the nucleoprotein gene of influenza A virus. J Virol (1990) 2.40
Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum (1995) 2.39
Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol (1997) 2.38
Perpetuation of influenza A viruses in Alaskan waterfowl reservoirs. Arch Virol (1995) 2.38
Mu1B, a novel adaptor medium chain expressed in polarized epithelial cells. FEBS Lett (1999) 2.37
Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase. J Virol (1992) 2.37
Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol (2001) 2.37
Predicting clopidogrel response using DNA samples linked to an electronic health record. Clin Pharmacol Ther (2011) 2.36
The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J (1997) 2.34
Regulation of adhesion of ICAM-1 by the cytoplasmic domain of LFA-1 integrin beta subunit. Science (1991) 2.34
Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology (2000) 2.33
Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med (2000) 2.31